• Profile
Close

Effect of oral contraceptives over 1-year on change in body composition profiles of women with polycystic ovary syndrome: A cohort study

Fertility and Sterility Sep 13, 2017

Kim Y, et al. - The impact of oral contraceptives (OC) over 1-year on the change in endocrine, metabolic and body composition profiles of women with polycystic ovary syndrome (PCOS) are assessed in this study. OC use more than 1 year could change androgen activity, lipid profiles and body composition for muscle and fat in PCOS women with normal BMI.

Methods

  • For this research, they performed a cohort study.
  • Total 187 of women with BMI<25 Kg/m2 and PCOS by Rotterdam criteria were selected in this study.
  • In this study, all subjective were follow-up to check endocrine, metabolic and body composition profiles with 1-year OC use.
  • Endocrine and metabolic profiles were examined by serum sample and body composition profiles were checked utilizing multi-frequency bioelectrical impedance examination.
  • Information were examined by Paired t-test and McNemar test where appropriate.

Results

  • In this study, after 1-year utilization of OC, SHBG (100.6±95.6 nmol/L vs. 171.5±52.1 nmol/L, P=0.002) and DHEAs (192.3±88.4 μg/dL vs. 228.8±110.6 μg/dL, P=0.002) were increased, and testosterone (0.9±0.5 ng/mL vs. 0.6±0.4 ng/mL, P<0.001), 17-α-OHP (2.3±1.6 ng/mL vs. 1.2±0.7 ng/mL, P<0.001) and AMH (12.5±10.0 ng/mL vs. 10.8±8.5 ng/mL, P=0.011) were reduced.
  • Utilizing 1-year OC increased total cholesterol (195.2±33.5 mg/dL vs. 201.8±32.5 mg/dL, P=0.007) and 25-OH vitamin D (16.2±9.5 ng/mL vs. 21.6±14.8 ng/mL, P=0.039).
  • For body composition profiles, protein mass (10.3±1.1 Kg vs. 10.1±1.1 Kg, P=0.004), mineral mass (2.4±0.2 Kg vs. 2.3±0.2 Kg, P=0.004), muscle mass (38.5±4.0 Kg vs. 37.7±4.1 Kg, P=0.004), fat free mass (40.8±4.2 Kg vs. 40.1±4.3 Kg, P=0.006) and basal metabolic rate (1364.5±102.0 Kcal vs. 1330.9±107.0 Kcal, P<0.001) were reduced with 1-year OC use.
  • With treatment of 1-year OC utilization, the proportion of women with abnormal free androgen index (≥5) was reduced 48.6% to 21.4% (P<0.001).
  • The proportion of women with abnormal HOMA-IR (>2) and abnormal percent body fat (>28%) were similar (52.9% vs. 57.1% and 34.3% vs. 31.4%, P>0.05 in both).

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay